|
Summary of Significant Accounting Policies (Details 4) (USD $)
|
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Intangible Asset disclosures | ||
| Impairment charges of long lived assets | $ 0us-gaap_ImpairmentOfLongLivedAssetsHeldForUse | $ 9,424us-gaap_ImpairmentOfLongLivedAssetsHeldForUse |
| Advertising costs | 8,000us-gaap_AdvertisingExpense | 37,000us-gaap_AdvertisingExpense |
| Research and development costs | $ 3,033,325us-gaap_ResearchAndDevelopmentExpense | $ 2,125,476us-gaap_ResearchAndDevelopmentExpense |
| Licensing agreements and patents | Minimum | ||
| Intangible Asset disclosures | ||
| Estimated useful life | 5 years | |
| Licensing agreements and patents | Maximum | ||
| Intangible Asset disclosures | ||
| Estimated useful life | 20 years | |
| X | ||||||||||
|
- Definition
Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|